Polyethyleneimine-mediated assembly of DNA nanotubes for KRAS siRNA delivery in lung adenocarcinoma therapy

J Mater Chem B. 2024 Jul 3;12(26):6442-6451. doi: 10.1039/d4tb00791c.

Abstract

Self-assembled DNA nanostructures hold great promise in biosensing, drug delivery and nanomedicine. Nevertheless, challenges like instability and inefficiency in cellular uptake of DNA nanostructures under physiological conditions limit their practical use. To tackle these obstacles, this study proposes a novel approach that integrates the cationic polymer polyethyleneimine (PEI) with DNA self-assembly. The hypothesis is that the positively charged linear PEI can facilitate the self-assembly of DNA nanostructures, safeguard them against harsh conditions and impart them with the cellular penetration characteristic of PEI. As a demonstration, a DNA nanotube (PNT) was successfully synthesized through PEI mediation, and it exhibited significantly enhanced stability and cellular uptake efficiency compared to conventional Mg2+-assembled DNA nanotubes. The internalization mechanism was further found to be both clathrin-mediated and caveolin-mediated endocytosis, influenced by both PEI and DNA. To showcase the applicability of this hybrid nanostructure for biomedical settings, the KRAS siRNA-loaded PNT was efficiently delivered into lung adenocarcinoma cells, leading to excellent anticancer effects in vitro. These findings suggest that the PEI-mediated DNA assembly could become a valuable tool for future biomedical applications.

MeSH terms

  • A549 Cells
  • Adenocarcinoma of Lung* / drug therapy
  • Adenocarcinoma of Lung* / pathology
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology
  • Cell Proliferation / drug effects
  • DNA / chemistry
  • Drug Carriers / chemistry
  • Humans
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / pathology
  • Nanotubes* / chemistry
  • Particle Size
  • Polyethyleneimine* / chemistry
  • Proto-Oncogene Proteins p21(ras)* / genetics
  • Proto-Oncogene Proteins p21(ras)* / metabolism
  • RNA, Small Interfering* / chemistry
  • RNA, Small Interfering* / pharmacology

Substances

  • Antineoplastic Agents
  • DNA
  • Drug Carriers
  • KRAS protein, human
  • Polyethyleneimine
  • Proto-Oncogene Proteins p21(ras)
  • RNA, Small Interfering